3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
19
Myelodysplastic Syndromes
7
Leukemia, Hairy Cell
4
Leukemia, Biphenotypic, Acute
4
Recurrence
3
Leukemia
3
Sarcoma, Myeloid
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Blast Crisis
2
Targeted Therapy
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myasthenia Gravis
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
13
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Bendamustine Hydrochloride
10
Magnetic Resonance Spectroscopy
9
Whole-Body Irradiation
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
Specimen Handling
7
CT-P10
7
Mycophenolic Acid
6
Biopsy
6
Doxorubicin
5
tafasitamab
4
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Cladribine
×
1 year
×
Clear all
No trials found.